← Back to Blog

New Study Reveals Why Keto Diets Raise Inflammation for Some People But Not Others

The ketogenic diet has a reputation for being both pro-inflammatory and anti-inflammatory, and both sides have evidence. A study published November 13, 2026 in Science Advances finally offers a molecular explanation for the contradiction: the fat you eat on keto may matter more than the carb restriction itself.

Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

A November 2026 study in Science Advances found that ketogenic diets high in long-chain saturated fatty acids promote proinflammatory macrophage activity through the cGAS-STING signaling pathway, while the same low-carbohydrate structure built around medium-chain or unsaturated fats does not. At the same time, the ketone body beta-hydroxybutyrate (BHB) produced on any ketogenic diet suppresses a separate inflammatory pathway, the NLRP3 inflammasome. Whether your keto diet lowers or raises your inflammation may come down to which of these two forces wins in your body, and that is shaped by the fats you are eating.

Millions of people follow ketogenic diets, and the conversation about whether keto is anti-inflammatory has been going on for years without a satisfying answer. Human trials show keto can reduce CRP in overweight adults. Other studies show inflammation rising on the same diet. Advocates say the fat burning and ketone production calm the immune system; critics point to the heavy saturated fat load common in many keto approaches and warn it could do the opposite. Both camps have data, and until recently nobody had a clear molecular explanation for why.

Research published November 13, 2026 in Science Advances provides that explanation. A team at the University of Texas San Antonio and the University of Cincinnati found that the inflammatory response to a ketogenic diet depends not on the low-carbohydrate structure itself, but on the specific type of fat making up most of the diet's calories. The finding adds important nuance to one of the most popular dietary patterns of the decade.

cGAS-STING signaling is an innate immune pathway originally evolved to detect foreign DNA from viruses and bacteria. Recent research has shown it can also be activated by mitochondrial stress inside the body's own cells, triggering a wave of inflammatory gene expression.

What the New Study Found

The research team fed mice different versions of a ketogenic diet and tracked the immune response in multiple tissues. Using a range of techniques including flow cytometry, RNA sequencing, and single-cell immunofluorescence, they found that the ketogenic diet promoted the accumulation of proinflammatory M1 macrophages across tissues. Macrophages are immune cells that patrol the body for threats, and their M1 form releases pro-inflammatory cytokines that drive systemic inflammation. The finding alone would be alarming for keto advocates, but the story was more complicated.

When the team looked at which fats were responsible, the picture sharpened considerably. In both mouse tissue cultures and human macrophage cell cultures, long-chain saturated fatty acids (LC-SFAs) consistently pushed macrophages toward the proinflammatory M1 state. Medium-chain fatty acids and unsaturated fatty acids produced no such effect. The researchers described this as a fat-type-specific phenomenon: it was not ketosis driving the inflammation, but the specific molecular structure of the longest saturated fat chains in the diet.

The team then mapped the metabolic changes underlying this response. Metabolomics analysis of macrophages from mice on a high-LC-SFA keto diet revealed enrichment of proinflammatory ceramides and hexosylceramides, a class of lipid-based signaling molecules that promote inflammatory gene expression. Transcriptomics showed multiple upregulated proinflammatory pathways, including inflammasome activation and, most strikingly, the cGAS-STING pathway. When the researchers bred mice with a myeloid-lineage-specific knockout of cGAS-STING, eliminating that pathway specifically in immune cells, the proinflammatory macrophage response to the high-LC-SFA keto diet disappeared. The pathway was not just correlated with the effect; it was required for it. According to PubMed, this study was published in Science Advances (PMID 43024707, doi: 10.1126/sciadv.aeg5542).

The clinical relevance of this work is in its implications for how keto diets are designed. A keto diet built primarily on butter, lard, palm shortening, and high-fat processed meats is heavy in long-chain saturated fat chains. A keto diet built on olive oil, avocado, fatty fish, macadamia nuts, and coconut-derived MCT oil sits in a very different fat category. The macros may look similar on paper, but the immune response in this research was sharply different.

The Role of Fat Type: Long-Chain, Medium-Chain, and Unsaturated

Not all fats in a ketogenic diet are alike, and the difference goes beyond the familiar saturated vs. unsaturated distinction. Long-chain saturated fatty acids are defined by carbon chain lengths from about 14 to 22 carbons. They are found in high concentrations in palm oil, palm shortening, lard, beef tallow, and some dairy fats. When these fats are metabolized inside macrophages, they appear to generate intermediate molecules, including the ceramide species identified in this study, that activate inflammatory signaling cascades.

Medium-chain fatty acids, with carbon chain lengths of 8 to 12, follow a different metabolic route. They are absorbed more directly into the bloodstream and transported to the liver for rapid conversion to ketone bodies, bypassing some of the cellular processing steps where LC-SFAs appear to trigger immune activation. Coconut oil contains a mixture of both medium-chain and longer-chain saturated fats, but pure MCT oil products concentrate the medium-chain forms specifically. The study found that medium-chain fatty acids did not drive M1 macrophage polarization in cell culture, suggesting they carry a lower inflammatory burden than their long-chain relatives.

Unsaturated fats, including both monounsaturated and polyunsaturated forms, also spared macrophages from the proinflammatory response in this research. This is consistent with a substantial literature showing that oleic acid (the main fat in olive oil) and omega-3 polyunsaturated fatty acids tend to steer macrophage activity toward resolution rather than inflammation. As reviewed in a 2023 paper in the International Journal of Molecular Sciences, macrophage polarization is profoundly shaped by lipid metabolism, with M2 anti-inflammatory macrophages preferentially relying on fatty acid oxidation pathways associated with unsaturated fat metabolism, while M1 proinflammatory states are associated with lipid species that include the ceramides elevated in this study (PMID 37569407, doi: 10.3390/ijms241512032).

The Ketone Paradox: BHB Is Still Anti-Inflammatory

The complicating factor is that ketogenic diets produce a metabolite that actively suppresses inflammation through an entirely separate pathway. When the body enters ketosis and shifts to fat burning, it produces the ketone body beta-hydroxybutyrate (BHB). A landmark 2015 study in Nature Medicine showed that BHB is a direct inhibitor of the NLRP3 inflammasome, one of the most important drivers of chronic low-grade inflammation in metabolic disease, autoimmunity, and aging. BHB blocks NLRP3 by preventing the potassium efflux that the inflammasome needs to assemble, and in both mouse models and human monocyte cultures it reduced IL-1 beta and IL-18 production (PMID 25686106, doi: 10.1038/nm.3804).

This sets up a genuine internal tug-of-war in someone following a high-saturated-fat ketogenic diet. The BHB being produced quiets the NLRP3 inflammasome, pushing in an anti-inflammatory direction. Meanwhile the LC-SFAs in the same diet activate cGAS-STING and ceramide-driven signaling, pushing in a proinflammatory direction. Which force dominates likely depends on the magnitude of each signal, which is shaped by the specific fat composition, the amount of ketosis achieved, and the individual's metabolic context. This mechanistic picture offers a genuinely satisfying explanation for why human keto trials have reported such variable inflammatory outcomes.

It also highlights a practical point: not all ketogenic diets produce the same amount of BHB. A well-formulated keto diet in a metabolically healthy person who is consistently in deep ketosis may generate enough BHB to offset some LC-SFA-driven inflammation. Someone who is dipping in and out of ketosis while eating a lot of saturated fat, without spending enough time in ketosis for BHB levels to rise meaningfully, may be getting the inflammatory downside of the fat composition without the anti-inflammatory ketone benefit.

What Human Trials Show About Keto and CRP

Human data on keto and CRP is limited but generally points in an anti-inflammatory direction when the diet is well controlled and participants are overweight. A 2024 systematic review and meta-analysis in the journal Nutrients pooled seven randomized controlled trials involving 218 overweight or obese adults following a ketogenic or control diet for 8 weeks to 2 years. Across those trials, the ketogenic diet produced a statistically significant reduction in CRP of 0.62 mg/dL on average (95% CI: -0.84 to -0.40). The effect on IL-6 was in the same direction but did not reach statistical significance (PMID 39683396, doi: 10.3390/nu16234002).

Seven trials is a small evidence base, however, and the meta-analysis could not standardize fat composition across studies. Some trials used Mediterranean-style keto approaches with olive oil as the primary fat; others used more conventional keto patterns heavier in animal products and saturated fats. If the November 2026 Science Advances paper's finding holds in human tissue, the variation in fat composition across those trials may partly explain why effect sizes differed. It is also worth noting that the human trials were all conducted in overweight or obese participants, a group where the weight loss on a keto diet may itself reduce inflammatory tone, making it harder to isolate the diet's direct effect on immune signaling.

Until larger trials comparing fat-type-matched keto approaches are conducted in humans, the mechanistic evidence from this new study is the best available guide. The researchers noted that a clinical trial is planned to investigate related questions in humans. That work will be important, but it will take years. In the meantime, the mouse and cell culture data provide a coherent framework for thinking about how fat quality on a ketogenic diet may shape inflammatory outcomes.

What This Means If You Are on a Keto Diet

The practical takeaway from this research is not that ketogenic diets raise inflammation, but that the fat composition of a ketogenic diet probably matters for the inflammatory response. A keto diet built primarily on olive oil, avocado, fatty fish, and nuts sits in a very different category from one built on butter, palm shortening, lard, and high-saturated-fat processed products. This distinction has not always been prominent in popular keto guidance, where the emphasis tends to be on hitting a macronutrient ratio rather than on fat quality.

For people using a ketogenic diet as a tool to manage or monitor their inflammatory levels, the type of fat chosen deserves attention. Practically, this means favoring oleic-acid-rich oils like extra-virgin olive oil and avocado oil as primary cooking fats, including fatty fish such as salmon, sardines, and mackerel as protein sources, and treating high-LC-SFA foods like palm shortening and processed keto snacks as occasional rather than everyday choices. These are fats the broader nutrition literature already associates with lower inflammatory markers, so the new mechanistic findings reinforce rather than overturn existing dietary guidance for inflammation management.

The only way to know how your body is actually responding is to measure. CRP, particularly high-sensitivity CRP, reflects the net output of everything influencing your immune and inflammatory tone, including diet composition, body weight, sleep, and stress. If you change your fat sources on a ketogenic diet and track CRP over several weeks, you will see whether the shift is making a measurable difference. For general wellness purposes, CRP is not a diagnostic test for any specific condition, but as a trend marker it offers information that guesswork cannot. Any persistent or unexpected elevation is worth discussing with a healthcare provider, who can interpret it in the context of your full health picture.

Sources

Share this article

Frequently Asked Questions

Does a ketogenic diet raise or lower inflammation?

It depends on the fat composition. A November 2026 Science Advances study found that ketogenic diets high in long-chain saturated fatty acids promote proinflammatory macrophage activity through the cGAS-STING pathway, while the same low-carb structure built on medium-chain or unsaturated fats does not. At the same time, the ketone body BHB produced on any keto diet suppresses the NLRP3 inflammasome, an anti-inflammatory effect. Human meta-analyses of randomized trials have generally found keto diets modestly lower CRP in overweight adults, but the fat quality used in those studies varied widely.

Which fats on a keto diet are most likely to raise inflammation?

Long-chain saturated fatty acids (LC-SFAs), typically found in palm oil shortening, lard, some heavily processed keto products, and high-saturated-fat dairy, were the fats linked to proinflammatory macrophage activation in the November 2026 research. Medium-chain fatty acids (found in MCT oil and coconut oil) and unsaturated fats (olive oil, avocado, nuts, fatty fish) did not trigger the same response in the study's mouse and cell culture experiments.

What is the cGAS-STING pathway and why does it matter for inflammation?

The cGAS-STING pathway is part of the innate immune system, originally evolved to detect foreign DNA from viruses and bacteria. Research has shown it can also be activated internally by mitochondrial stress. When activated, it drives the expression of interferons and proinflammatory cytokines. The November 2026 Science Advances study found that long-chain saturated fatty acids activate this pathway in macrophages, and that knocking out cGAS-STING in immune cells prevented the proinflammatory response to a high-LC-SFA ketogenic diet in mice.

How do I know if my keto diet is affecting my inflammation levels?

CRP, particularly high-sensitivity CRP, is the standard blood marker for systemic inflammation and reflects the net influence of all factors driving your immune response, including diet composition, body weight, sleep, and stress. Measuring CRP before and after changing your fat sources on a ketogenic diet gives you an objective trend to track. Any persistent or unexpected elevation is worth discussing with a healthcare provider, who can interpret it alongside your broader health picture. CRP is a general wellness marker, not a diagnosis of any specific condition.

Want to track how your diet choices affect your inflammation?

Sensa is a general wellness tool that lets you measure your CRP levels at home with a saliva sample. No needles, no clinic visit. Track trends over time and see how dietary changes move the needle.

Buy Now

Get inflammation insights in your inbox

New articles on inflammation science, plus updates on the Sensa at-home CRP test and app.